SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: telephonics who wrote (1978)2/9/2002 2:13:58 PM
From: Cacaito  Respond to of 2515
 
telep, the super HYPE case of the young woman at best is anecdote (the lowest level of scientific evidence). Anecdotical "evidence" in clinical medicine are generally full with bias and the source of numerous disasters in the history of Medicine.

In any case, the trial presented to the FDA was about "tumor shrinkage", not at all about increase survival.

The drug has NOT being proven effective to save lives. It is Imcl moral and scientific duty to do so.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News